… -associated disease in vaccinated individuals. To derive the greatest public health benefit,
HPV vaccines offering protection from cervical cancer and genital warts will, ideally, be …

… bivalent HPV vaccination coverage and a decline in genital warts diagnoses in women.6
Importantly, the study provides new evidence of a herd-protective effect of HPV vaccination in …

… vaccine introduction. No study has specifically examined the effects of HPV vaccination on
genital warts … We examined changes in rates of HPV vaccination and genital wart diagnoses …

… quadrivalent HPV vaccine also provides protection against genital warts … HPV vaccination
status, HPV DNA status, and other HPV-associated clinical outcomes to evaluate HPV vaccine …

… HPV types 6 and 11 cause 90 to 95 percent of genital warts. … marketing of HPV vaccine to
older women already exposed to HPV, … is already routine, HPV vaccination will not significantly …

… human papillomavirus vaccine is active against virus subtypes that cause genital warts in
men and … of human immunodeficiency virus, human papillomavirus, and herpes simplex virus. …

… , HPV knowledge, and attitudes about HPV vaccination. Intention to administer each of
two HPV vaccines types (a cervical cancer/genital wart vaccine and a cervical cancer …

… of HPV-related cancers, precancers, and genital warts. … of HPV vaccines requires a
demonstration that vaccination reduces the incidence of CIN 2 and 3 or AIS caused by vaccine HPV …

… The quadrivalent vaccine injections are administered in … in preventing genital wart formation
in patients naïve to HPV … HPV vaccination will decrease the burden of genital warts and …

… human papillomavirus (HPV) vaccine was introduced in the Portuguese National Immunization
… the impact of HPV vaccination on the epidemiology of genital warts (GWs) in Portugal. …